Acer therapeutics announces promotion of tanya hayden to chief operating officer

Newton, mass., june 21, 2022 (globe newswire) -- acer therapeutics inc. (nasdaq: acer), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced the promotion of tanya hayden to chief operating officer (coo). harry s. palmin, who had been serving as the company's chief operating officer as well as its chief financial officer, will continue to serve as the company's chief financial officer.
ACER Ratings Summary
ACER Quant Ranking